Long-term Elmiron users face increased eye damage and vision loss risk, new study confirms

A recent study has provided more evidence linking the interstitial cystitis drug Elmiron (pentosan polysulfate sodium) to an increased risk of vision problems. The new study, published in the scientific journal Retina, found that the link between Elmiron and eye damage was higher for patients who had used the medication for an extended period. (more…)

By |2021-02-05T15:35:26+00:00February 5th, 2021|Elmiron|Comments Off on Long-term Elmiron users face increased eye damage and vision loss risk, new study confirms

Legal experts predict hundreds of Elmiron eye damage lawsuits in 2021

Janssen Pharmaceuticals and Johnson & Johnson, the manufacturers of the interstitial cystitis drug Elmiron (pentosan polysulfate sodium) are currently facing at least 80 lawsuits that have been filed on behalf of patients who developed vision problems after using this medication. (more…)

By |2020-12-17T15:47:48+00:00December 17th, 2020|Elmiron|Comments Off on Legal experts predict hundreds of Elmiron eye damage lawsuits in 2021

What types of eye damage have been linked to Elmiron?

In 2018, researchers uncovered evidence that patients using the interstitial cystitis drug Elmiron (pentosan polysulfate sodium) were at risk of developing serious and potentially permanent eye damage. In the two years since this evidence was first uncovered, other scientists have confirmed that Elmiron users may develop eye damage that can lead to vision loss or blindness. (more…)

By |2020-11-20T18:02:28+00:00November 20th, 2020|Elmiron|Comments Off on What types of eye damage have been linked to Elmiron?

New Elmiron studies confirm risk of eye damage from interstitial cystitis drug

The first study linking the interstitial cystitis drug Elmiron (pentosan polysulfate sodium) to an increased risk of eye damage was published in 2018. In the two years since, dozens of additional studies have confirmed that Elmiron users may develop vision loss, blindness, retinal toxicity, or other vision problems due to the side effects of this drug. (more…)

By |2020-10-19T17:11:45+00:00October 19th, 2020|Elmiron|Comments Off on New Elmiron studies confirm risk of eye damage from interstitial cystitis drug

Elmiron lawsuits filed across the U.S. by patients with eye damage

Several studies published in recent years have linked the interstitial cystitis drug Elmiron (pentosan polysulfate sodium) to an increased risk of eye damage, including loss of vision, retinal toxicity, pigmentary maculopathy, and even blindness. (more…)

By |2020-10-19T17:12:52+00:00September 15th, 2020|Elmiron|Comments Off on Elmiron lawsuits filed across the U.S. by patients with eye damage

J&J, Janssen face class action lawsuit over permanent eye damage caused by Elmiron

A Nevada woman who suffered permanent retinal damage in both eyes after using the bladder drug Elmiron filed a class action lawsuit against the makersof the drug in Pennsylvania. Tina Pisco’s class action against Johnson & Johnson and Janssen Pharmaceuticals alleges that the drugmakers knew the risk of eye damage associated with Elmiron, but failed to properly warn doctors and patients. (more…)

By |2020-10-22T14:49:51+00:00August 24th, 2020|Elmiron|Comments Off on J&J, Janssen face class action lawsuit over permanent eye damage caused by Elmiron

Elmiron may cause serious eye damage, study finds

Recent studies have shown that patients treated with the drug Elmiron over an extended period are at risk of developing retinal damage, vision loss, and even blindness. According to one study, 25% of patients treated with Elmiron for five years or more developed vision problems as a result of taking the drug. (more…)

By |2020-10-19T16:48:43+00:00July 28th, 2020|Elmiron|Comments Off on Elmiron may cause serious eye damage, study finds
Go to Top